THE US Food and Drug
Administration has approved
Osphena (ospemifene) to treat
women experiencing moderate to
severe dyspareunia (pain during
sexual intercourse), a symptom of
vulvar and vaginal atrophy due to
menopause.
Osphena, a pill taken with food
once daily, acts like estrogen on
vaginal tissues to make them
thicker and less fragile.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Mar 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Mar 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.